hydroxyindoleacetic acid has been researched along with fluvoxamine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artigas, F; Bel, N | 3 |
| Alvarez, E; Artigas, F; Celada, P; Dolera, M | 1 |
| Den Boer, JA; Westenberg, HG | 1 |
| Adinoff, B; Bone, G; Eckardt, MJ; Linnoila, M; Martin, P; Roehrich, L; Rubinow, D; Stapleton, JM | 1 |
| Adinoff, B; Bone, GA; Eckardt, MJ; Lane, EA; Linnoila, M; Martin, PR; Rubinow, DR; Stapleton, JM | 1 |
| Brouwer, GJ; Doogan, D; Klok, CJ; van Praag, HM | 1 |
| Baba, T; Lee, JW; Shibuya, T; Takada, K; Takeda, H | 1 |
| Adinoff, B; Bone, GA; Eckardt, MJ; Lane, E; Linnoila, M; Martin, PR; Stapleton, JM; Weingartner, H | 1 |
| Banki, CM | 1 |
| Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S | 1 |
| Artigas, F; Bel, N; Casanovas, JM; Romero, L | 1 |
| Bardgett, ME; Csernansky, JG; Sheline, Y | 1 |
| Finberg, JP; Klein, E; Shachar, D; Tabak, A | 1 |
| Egashira, T; Matsumiya, T; Takada, K; Takayama, F; Takeda, H; Yamanaka, Y | 1 |
| Nakamura, J; Shinkai, K; Terao, T; Ueda, N; Yoshimura, R | 1 |
| Kitagami, T; Miura, H; Ohta, T; Ozaki, N; Qiao, H | 1 |
| Breuer, ME; Olivier, B; van der Stelt, HM; Westenberg, HG | 1 |
| Chidori, S; Egashira, N; Fujiwara, M; Iwasaki, K; Kawabe, H; Matsuda, T; Mishima, K; Nishimura, R; Takashima, A; Watanabe, T | 1 |
| Birkenhäger, TK; Bruijn, JA; Fekkes, D; Moleman, P; Mulder, PG; van den Broek, WW | 1 |
| Danhof, M; Freijer, JI; Geldof, M; Peletier, LA; van Beijsterveldt, L | 1 |
6 trial(s) available for hydroxyindoleacetic acid and fluvoxamine
| Article | Year |
|---|---|
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin | 1990 |
Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: a preliminary study.
Topics: Aged; Alcohol Amnestic Disorder; Dementia; Double-Blind Method; Ethanol; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Middle Aged; Oximes; Substance-Related Disorders | 1988 |
Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings.
Topics: Aged; Alcohol Amnestic Disorder; Clinical Trials as Topic; Double-Blind Method; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Male; Memory; Middle Aged; Oximes; Psychoses, Alcoholic; Serotonin Antagonists; Somatostatin; Wechsler Scales | 1989 |
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
Topics: Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Depression; Diazepam; Double-Blind Method; Electrocardiography; Female; Fluvoxamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Middle Aged; Oximes; Psychiatric Status Rating Scales | 1981 |
Fluvoxamine treatment of alcoholic amnestic disorder.
Topics: Aged; Alcohol Amnestic Disorder; Cognition; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Time Factors; Treatment Outcome | 1995 |
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1997 |
16 other study(ies) available for hydroxyindoleacetic acid and fluvoxamine
| Article | Year |
|---|---|
Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.
Topics: Animals; Dialysis; Extracellular Space; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Raphe Nuclei; Rats; Serotonin | 1992 |
Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.
Topics: Adult; Blood Platelets; Depressive Disorder; Extracellular Space; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin | 1992 |
Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei.
Topics: Analysis of Variance; Animals; Extracellular Space; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Microdialysis; Organ Specificity; Raphe Nuclei; Rats; Reference Values; Serotonin | 1993 |
[Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic].
Topics: Administration, Oral; Amygdala; Animals; Biogenic Monoamines; Fluvoxamine; Hippocampus; Hydroxyindoleacetic Acid; Imipramine; Limbic System; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Prophylactic potential of selective reuptake inhibitors in suicidal patients.
Topics: Binding Sites; Depressive Disorder; Fluvoxamine; Frontal Lobe; Humans; Hydroxyindoleacetic Acid; Imipramine; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted | 1995 |
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats.
Topics: Animals; Brain; Cerebral Cortex; Fluvoxamine; Hydroxyindoleacetic Acid; Male; Microdialysis; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 1996 |
Adaptative changes of the serotonergic system after antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Imipramine; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Pyrimidines; Raphe Nuclei; Rats; Serotonin; Stereotaxic Techniques; Tranylcypromine; Tryptophan | 1996 |
Effect of single and repeated administration of fluvoxamine on noradrenaline release in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cerebral Cortex; Corpus Striatum; Fluvoxamine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 1997 |
Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine.
Topics: Animals; Circadian Rhythm; Fluvoxamine; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2000 |
Characteristics of fluvoxamine-induced nausea.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Benzamides; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Morpholines; Nausea; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2001 |
Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Disease Models, Animal; Dopamine; Exploratory Behavior; Fluvoxamine; Hippocampus; Hydroxyindoleacetic Acid; Male; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Isolation; Stress, Psychological | 2005 |
Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study.
Topics: Animals; Area Under Curve; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Enzyme Inhibitors; Exploratory Behavior; Fenfluramine; Fluvoxamine; Hydrazines; Hydroxyindoleacetic Acid; Male; Microdialysis; Multivariate Analysis; Olfaction Disorders; Olfactory Bulb; Olfactory Pathways; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 2005 |
Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Brain Chemistry; Depressive Disorder; Disease Models, Animal; Extracellular Fluid; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Mice; Mice, Transgenic; Microdialysis; Motor Activity; Mutation; Neurons; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; tau Proteins; Up-Regulation | 2005 |
Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Blood Platelets; Depressive Disorder; Drug Resistance; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Imipramine; Lithium Compounds; Male; Middle Aged; Psychiatric Status Rating Scales; Serotonin | 2007 |
Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex.
Topics: Animals; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Models, Biological; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin | 2008 |